Work

Erythromycin repurposing for hepatocellular carcinoma treatment: Targeting CD24 to enhance anti-tumor immunity

Year: 2025

Type: article

Source: European Journal of Pharmacology

DOI: 10.1016/j.ejphar.2025.177457

Authors: Mingguang Shao, Tiesuo Zhao, Li Qian, Xiaolong Jia, Xiaolong Jia, Zhihan Chen, Kangle Wang, Yuanli Sun, Xiaoyu Dong, Jiaxin Geng, Yongxi Zhang, Sheng Guo, Zishan Yang, Tian Wei, Huijie Jia

Institutions: Henan Medical University, Heze Vocational College of Home Economics, Xinxiang University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Xinxiang Medical University, Henan Provincial Science and Technology Research Project

Awards: G1980704201, G786605774

OpenAlex ID: W4408240691

FWCI: 3.305

Cites: 26

Cited by: 7

Related to: 10